Global Human cytomegalovirus 65 kDa Phosphoprotein Market Research Report 2019

Table of Contents

Executive Summary

1 Human cytomegalovirus 65 kDa Phosphoprotein Market Overview

• 1.1 Product Overview and Scope of Human cytomegalovirus 65 kDa Phosphoprotein
• 1.2 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Type
  • 1.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 HB-101
  • 1.2.3 CyMVectin
  • 1.2.4 ASP-0113
  • 1.2.5 PepVax
  • 1.2.6 Others
• 1.3 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Application
  • 1.3.1 Human cytomegalovirus 65 kDa Phosphoprotein Consumption Comparison by Application (2014-2025)
  • 1.3.2 Brain Tumor
  • 1.3.3 Hemotaological Tumor
  • 1.3.4 Kidney Transplant Rejection
  • 1.3.5 Liver Transplant Rejection
  • 1.3.6 Others
• 1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Market by Region
  • 1.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size
  • 1.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (2014-2025)
  • 1.4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Production (2014-2025)

2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Competition by Manufacturers

• 2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Production Sites, Area Served, Product Types
• 2.5 Human cytomegalovirus 65 kDa Phosphoprotein Market Competitive Situation and Trends
  • 2.5.1 Human cytomegalovirus 65 kDa Phosphoprotein Market Concentration Rate
  • 2.5.2 Human cytomegalovirus 65 kDa Phosphoprotein Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Regions

• 3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Regions
• 3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions (2014-2019)
• 3.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Human cytomegalovirus 65 kDa Phosphoprotein Production
  • 3.4.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019)
  • 3.4.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Human cytomegalovirus 65 kDa Phosphoprotein Production
  • 3.5.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019)
  • 3.5.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Human cytomegalovirus 65 kDa Phosphoprotein Production (2014-2019)
  • 3.6.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019)
  • 3.6.2 China Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Human cytomegalovirus 65 kDa Phosphoprotein Production (2014-2019)
  • 3.7.1 Japan Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate (2014-2019)
  • 3.7.2 Japan Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Regions

• 4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Regions
• 4.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Consumption (2014-2019)
• 4.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Consumption (2014-2019)
• 4.4 China Human cytomegalovirus 65 kDa Phosphoprotein Consumption (2014-2019)
• 4.5 Japan Human cytomegalovirus 65 kDa Phosphoprotein Consumption (2014-2019)

5 Global Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price Trend by Type

• 5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Market Share by Type (2014-2019)
• 5.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type (2014-2019)
• 5.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Type (2014-2019)
• 5.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Growth by Type (2014-2019)

6 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis by Applications

• 6.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Share by Application (2014-2019)
• 6.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Human cytomegalovirus 65 kDa Phosphoprotein Business

• 7.1 Astellas Pharma Inc
  • 7.1.1 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.1.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Hookipa Biotech AG
  • 7.2.1 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.2.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Immunomic Therapeutics Inc
  • 7.3.1 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.3.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Vakzine Projekt Management GmbH
  • 7.4.1 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.4.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Vaximm AG
  • 7.5.1 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.5.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 VBI Vaccines Inc
  • 7.6.1 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.6.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Vical Inc
  • 7.7.1 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production Sites and Area Served
  • 7.7.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction, Application and Specification
  • 7.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served

8 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Cost Analysis

• 8.1 Human cytomegalovirus 65 kDa Phosphoprotein Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein
• 8.4 Human cytomegalovirus 65 kDa Phosphoprotein Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Human cytomegalovirus 65 kDa Phosphoprotein Distributors List
• 9.3 Human cytomegalovirus 65 kDa Phosphoprotein Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast

• 11.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue Forecast
  • 11.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price and Trend Forecast (2019-2025)
• 11.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue Forecast (2019-2025)
• 11.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast (2019-2025)
  • 11.3.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast (2019-2025)
  • 11.3.3 China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast (2019-2025)
  • 11.3.4 Japan Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast (2019-2025)
• 11.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Human cytomegalovirus 65 kDa Phosphoprotein Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List